We're looking forward to the upcoming LSPN North America Spring 2024 conference, that's taking place in Massachusetts this month.
Now in its 6th year, the theme for this year's conference is 'leveraging and protecting innovation in the life sciences'. The programme will deliver an overview of the latest rulings and legislative developments, as well as providing a platform for professionals to share their solutions to everyday IP challenges.
We're proud to sponsor this event and help bring together in-house patent counsel from leading pharmaceutical and biotechnology companies.
Date: 8 – 9 May 2024
Location: Boston, Massachusetts, USA
On the conference agenda
Roundtable: Essential considerations for avoiding priority pitfalls
We're hosting a roundtable on Day 2 of the conference, talking about the importance of the four pillars for a successful claim to a priority document from Article 4 of the Paris Convention, especially when preparing a global patent portfolio.
Time: 11:30-13:05 (EDT)
Date: Thursday 9 May 2024
Meet the HLK team attending LSPN North America Spring 2024
At HLK, we enjoy developing long-standing, collaborative relationships, and aim to understand our client's business needs. Our team has a wealth of experience across the IP lifecycle in the pharma and life sciences field.
Meet our experts who'll be at the conference and the gala dinner the evening before.
Joseph Lenthall
Partner | UK and European Patent Attorney | UPC Representative
Joe is a leading Chemistry & Life Sciences EPO Opposition and Appeal specialist. He is particularly adept at handling complex multi-party Oppositions and Appeals. Recent highlights include defending EP patents covering small molecule splicing modulator therapies, CRISPR gene-editing therapies, protein kinase inhibitors, companion diagnostics, ADCs, thin film drug delivery technology, and foods incorporating recombinant proteins.
Joe's opposition practice feeds back into the team's drafting and prosecution practice to ensure robust patent protection for commercially significant products. Joe has particular expertise in the fields of therapeutics (including secondary protection through formulations, drug delivery, dosage regimes and patient stratification), diagnostics, biocatalysis and microbial fermentation.
David Hammond
Partner | UK and European Patent Attorney
David is a partner in the Chemistry and Life Sciences team. With degrees in both chemistry and DNA technology, David is many of our clients' go-to attorney for innovations in the medical area. He advises our clients on a range of healthcare technologies including diagnostics and biomarkers, gene therapy, small molecule pharma, antibodies and peptides, microfluidics and medical devices.
David's academic calibre, deep knowledge of patent systems in many countries and commercial approach allow him to draft and prosecute applications that secure protection across the world for his clients. David is also a key member of HLK's Oppositions and Appeals team, helping his clients defend their patents when challenged, and attack their competitors' patents when required.
David has a deep understanding of the in-house environment through several long-term secondments and his clients value his strategic and business-focussed approach, and appreciate the clear, commercially-focussed advice he gives.
Lisa Williams
Partner | UK and European Patent Attorney
Lisa is a partner in our cross-disciplinary Life Sciences & Healthcare team who is notable for the strong relationships she establishes with the clients and inventors she works with.
Lisa's practice covers a range of technologies, with particular focus in the areas of healthcare and medical devices. This includes drafting and prosecuting patent applications relating to medical devices, diagnostics, drug delivery systems, patient monitoring, and the management of healthcare and medical data. Lisa also handles patent applications relating to software, AI, and machine learning in the healthcare and medical device field.
Most of Lisa's time is spent working with large multinational European companies and clients in the US, which means that she has an appreciation for the differing laws and practices. She also has particular experience working with high-tech start-ups, through her associations with incubators, and gained valuable in-house experience having completed a secondment at a leading audio electronics company.
